Use of type IA antiarrhythmic agents to lower blood lipids

Details Use of type IA antiarrhythmic agents to lower blood lipids Use of type IA antiarrhythmic agents to lower blood lipids

1991-06-10

1992-11-24

Griffin, Ronald W.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

514 57, 514 60, 514210, 514357, 424440, 424455, A61K 922, A61K 31715, A61K 3120

Patent

active

051661420

ABSTRACT:
A method is provided to lower serum cholesterol, total triglycerides and/or apoprotein B in a human by administering an effective amount of one or more Type IA antiarrhythmic agents to said human.

REFERENCES:
patent: 3864347 (1975-02-01), Gutzwiller et al.
patent: 3898237 (1975-08-01), Grethe et al.
Surewicz et al; Biochem Pharmacol 32(9); 1983; 1467-1472; Abstract only.
The Expert Panel, Arch. Intern. Med. 148: 36-69 (1988).
J. C. Rosa, Circulation 81: 1721-1733 (1990).
S. Yusef et al., JAMA 260: 2259-2263 (1988).
Members of the Working Group on Management of Patients with Hypertension and High Blood Cholesterol, Ann. of Intern. Med. 144: 224 (1991).
J. T. Bigger et al., in The Pharmacologic Basis of Therapeutics, pp. 748-783, A. G. Gillman et al. (eds.), MacMillan, N.Y. (1985).
E. Carmeliet et al., in "Clinical Aspects of Life-Threatening Arrhythmias," H. M. Greenberg et al. (eds.), Ann. N.Y. Acad. Sciences 427: 1-15 (1984).
E. M. V. Williams, J. Clin. Pharmacol. 24: 129-147 (1984).
The Multicenter Diltiazem Post-Infection Trial (MDPIT) Research Group, New Engl. J. Med. 319: 385-392 (1988).
S. G. Young, Circulation 82: 1574-1594 (1990).
The Merck Index (11th ed.), S. Budaveri (ed.), Merck & Co., Inc., Rahway, N.J. (1989).
Remington's Pharmaceutical Sciences (16th ed.), A. Osol (ed.), Mack Publishing Co., Easton, Pa. (1980).
H. A. Tyroler, Circulation 76: 515-522 (1987).
Lipid Research Clinics Program, JAMA 251: 351-364 (1984).
W. T. Friedewald et al., Clin. Chem. 18:499-502 (1972).

Affiliated with

Also associated with

Rating

Use of type IA antiarrhythmic agents to lower blood lipids does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of type IA antiarrhythmic agents to lower blood lipids, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of type IA antiarrhythmic agents to lower blood lipids will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-921736